Author:
Cecchi Enrica,Capone Laura,Ruocco Carlo,Fazzini Alessandro,Mugelli Alessandro,Giotti Alberto,Failli Paola
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Cardiology and Cardiovascular Medicine,Pharmacology,General Medicine
Reference19 articles.
1. Grant SM, Goa KL. Iloprost: A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in peripheral vascular disease, myocardial ischaemia and extracorporeal circulation procedures.Drugs 1992;43:889?924.
2. European Working Group on Critical Leg Ischaemia. Second European Consensus Document on Chronic Critical Leg Ischaemia.Circulation 1991;84(Suppl 4):IV1-IV26.
3. Sir Colin Dollery (ed).Therapeutic Drugs. Edinburgh: Churchill Livingstone, 1991:115?118.
4. St�rzebecher CS, Losert W. Effects of iloprost on platelet activation in vitro. In: Gryglewsky RJ, Stock G, eds.Prostacyclin and its Stable Analogue Iloprost. Berlin: Springer-Verlag, 1987:39?45.
5. Nicolini FA, Metha P, Lawson D, Metha JL. Reduction in human neutrophil chemotaxis by the prostacyclin analogue iloprost.Thromb Res 1990;59:669?674.